|
1
|
Chakradhar S: Colorectal cancer: 5 big
questions. Nature. 521:S162015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawla P, Sunkara T and Barsouk A:
Epidemiology of colorectal cancer: Incidence, mortality, survival,
and risk factors. Prz Gastroenterol. 14:89–103. 2019.PubMed/NCBI
|
|
4
|
Andre T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan
P, Bridgewater J, et al: Oxaliplatin, fluorouracil, and leucovorin
as adjuvant treatment for colon cancer. N Engl J Med.
350:2343–2351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Teng WJ, Chen P, Zhu FY, Di K, Zhou C,
Zhuang J, Cao XJ, Yang J, Deng LJ and Sun CG: Effect of Rhizoma
paridis total saponins on apoptosis of colorectal cancer cells and
imbalance of the JAK/STAT3 molecular pathway induced by IL-6
suppression. Genet Mol Res. 14:5793–5803. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Attar R, Tabassum S, Fayyaz S, Ahmad MS,
Nogueira DR, Yaylim I, Timirci-Kahraman O, Kucukhuseyin O, Cacina
C, Farooqi AA and Ismail M: Natural products are the future of
anticancer therapy: Preclinical and clinical advancements of viscum
album phytometabolites. Cell Mol Biol (Noisy-le-Grand). 61:62–68.
2015.PubMed/NCBI
|
|
7
|
da Rocha AB, Lopes RM and Schwartsmann G:
Natural products in anticancer therapy. Curr Opin Pharmacol.
1:364–369. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang C, Li C, Jia X, Wang K, Tu Y, Wang
R, Liu K, Lu T and He C: In vitro and in vivo anti-inflammatory
effects of polyphyllin VII through downregulating MAPK and NF-kB
pathways. Molecules. 24:8752019. View Article : Google Scholar
|
|
9
|
Wu Z and Zhang J, Xu F, Wang Y and Zhang
J: Rapid and simple determination of polyphyllin I, II, VI, and VII
in different harvest times of cultivated Paris polyphylla Smith
var. yunnanensis (Franch.) Hand.-Mazz by UPLC-MS/MS and FT-IR. J
Nat Med. 71:139–147. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin Z, Liu Y, Li F, Wu J, Zhang G, Wang Y,
Lu L and Liu Z: Anti-lung cancer effects of polyphyllin VI and VII
potentially correlate with apoptosis in vitro and in vivo.
Phytother Res. 29:1568–1576. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen JC, Hsieh MJ, Chen CJ, Lin JT, Lo YS,
Chuang YC, Chien SY and Chen MK: Polyphyllin G induce apoptosis and
autophagy in human nasopharyngeal cancer cells by modulation of AKT
and mitogen-activated protein kinase pathways in vitro and in vivo.
Oncotarget. 7:70276–70289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Jia X, Bao J, Chen S, Wang K,
Zhang Y, Li P, Wan JB, Su H, Wang Y, et al: Polyphyllin VII induces
apoptosis in HepG2 cells through ROS-mediated mitochondrial
dysfunction and MAPK pathways. BMC Complement Altern Med.
16:582016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang F, Liu H, Zhao J, Ma X and Qi W:
POLR1B is upregulated and promotes cell proliferation in non-small
cell lung cancer. Oncol Lett. 19:671–680. 2020.PubMed/NCBI
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: CytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Minguez P, Letunic I, Parca L and Bork P:
PTMcode: A database of known and predicted functional associations
between post-translational modifications in proteins. Nucleic Acids
Res. 41:D306–D311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai YT, Lai JN, Lo PC, Chen CN and Lin
JG: Prescription of Chinese herbal products is associated with a
decreased risk of invasive breast cancer. Medicine (Baltimore).
96:e79182017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sparber A, Jonas W, White J, Derenzo E,
Johnson E and Bergerson S: Cancer clinical trials and subject use
of natural herbal products. Cancer Invest. 18:436–439. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spaulding-Albright N: A review of some
herbal and related products commonly used in cancer patients. J Am
Diet Assoc. 97 (Suppl 10):S208–S215. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu Y, Si Y, Xiang Y, Zhou T, Liu X, Wu M,
Li W, Zhang T, Xiang K, Zhang L, et al: Polyphyllin I activates
AMPK to suppress the growth of non-small-cell lung cancer via
induction of autophagy. Arch Biochem Biophys. 687:1082852020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong R, Guo J, Zhang Z, Zhou Y and Hua Y:
Polyphyllin I inhibits gastric cancer cell proliferation by
downregulating the expression of fibroblast activation protein
alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated
fibroblasts. Biochem Biophys Res Commun. 497:1129–1134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He DX, Li GH, Gu XT, Zhang L, Mao AQ, Wei
J, Liu DQ, Shi GY and Ma X: A new agent developed by
biotransformation of polyphyllin VII inhibits chemoresistance in
breast cancer. Oncotarget. 7:31814–31824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang D, Liu S, Liu Z, Ma C, Jiang Y, Sun
C, Li K, Cao G, Lin Z, Wang P, et al: Polyphyllin I induces cell
cycle arrest in prostate cancer cells via the upregulation of IL6
and P21 expression. Medicine (Baltimore). 98:e177432019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsieh MJ, Chien SY, Lin JT, Yang SF and
Chen MK: Polyphyllin G induces apoptosis and autophagy cell death
in human oral cancer cells. Phytomedicine. 23:1545–1554. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hong F, Gu W, Jiang J, Liu X and Jiang H:
Anticancer activity of polyphyllin I in nasopharyngeal carcinoma by
modulation of lncRNA ROR and P53 signalling. J Drug Target.
27:806–811. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang M, Zou J, Zhu H, Liu S, Wang H, Bai P
and Xiao X: Paris saponin II inhibits human ovarian cancer
cell-induced angiogenesis by modulating NF-kB signaling. Oncol Rep.
33:2190–2198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lou W, Chen Y, Zhu KY, Deng H, Wu T and
Wang J: Polyphyllin I overcomes EMT-associated resistance to
erlotinib in lung cancer cells via IL-6/STAT3 pathway inhibition.
Biol Pharm Bull. 40:1306–1313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng R, Jiang H, Li J, Liu X and Xu H:
Polyphyllin II restores sensitization of the resistance of PC-9/ZD
cells to gefitinib by a negative regulation of the PI3K/Akt/mTOR
signaling pathway. Curr Cancer Drug Targets. 17:376–385. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cui J, Man S, Cui N, Yang L, Guo Q, Ma L
and Gao W: The synergistic anticancer effect of formosanin C and
polyphyllin VII based on caspase-mediated cleavage of Beclin1
inhibiting autophagy and promoting apoptosis. Cell Prolif.
52:e125202019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang P, Yang Q, Du X, Chen Y and Zhang T:
Targeted regulation of Rell2 by microRNA-18a is implicated in the
anti-metastatic effect of polyphyllin VI in breast cancer cells.
Eur J Pharmacol. 851:161–173. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Joung J, Engreitz JM, Konermann S,
Abudayyeh OO, Verdine VK, Aguet F, Gootenberg JS, Sanjana NE,
Wright JB, Fulco CP, et al: Genome-scale activation screen
identifies a lncRNA locus regulating a gene neighbourhood. Nature.
548:343–346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Parikshak NN, Swarup V, Belgard TG, Irimia
M, Ramaswami G, Gandal MJ, Hartl C, Leppa V, Ubieta LT, Huang J, et
al: Genome-wide changes in lncRNA, splicing, and regional gene
expression patterns in autism. Nature. 540:423–427. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawasaki Y, Miyamoto M, Oda T, Matsumura
K, Negishi L, Nakato R, Suda S, Yokota N, Shirahige K and Akiyama
T: The novel lncRNA CALIC upregulates AXL to promote colon cancer
metastasis. EMBO Rep. 20:e470522019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meng S, Jian Z, Yan X, Li J and Zhang R:
LncRNA SNHG6 inhibits cell proliferation and metastasis by
targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer.
Mol Med Rep. 20:2541–2548. 2019.PubMed/NCBI
|
|
41
|
Cui M, Chen M, Shen Z, Wang R, Fang X and
Song B: LncRNA-UCA1 modulates progression of colon cancer through
regulating the miR-28-5p/HOXB3 axis. J Cell Biochem. Jan
16–2019.(Epub ahead of print). View Article : Google Scholar
|
|
42
|
He Z, Dang J, Song A, Cui X, Ma Z and
Zhang Z: NEAT1 promotes colon cancer progression through sponging
miR-495-3p and activating CDK6 in vitro and in vivo. J Cell
Physiol. 234:19582–19591. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu Q, Meng WY, Jie Y and Zhao H: LncRNA
MALAT1 induces colon cancer development by regulating
miR-129-5p/HMGB1 axis. J Cell Physiol. 233:6750–6757. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang X, Liu W, Xu X, Zhu J, Wu Y, Zhao K,
He S, Li M, Wu Y, Zhang S, et al: Downregulation of long noncoding
RNA UCA1 enhances the radiosensitivity and inhibits migration via
suppression of epithelialmesenchymal transition in colorectal
cancer cells. Oncol Rep. 40:1554–1564. 2018.PubMed/NCBI
|
|
45
|
Ji Q, Cai G, Liu X, Zhang Y, Wang Y, Zhou
L, Sui H and Li Q: MALAT1 regulates the transcriptional and
translational levels of proto-oncogene RUNX2 in colorectal cancer
metastasis. Cell Death Dis. 10:3782019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Braicu C, Buse M, Busuioc C, Drula R,
Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, et al: A
comprehensive review on MAPK: A promising therapeutic target in
cancer. Cancers (Basel). 11:16182019. View Article : Google Scholar
|
|
47
|
Yoshida Y, Tsunoda T, Doi K, Tanaka Y,
Fujimoto T, Machida T, Ota T, Koyanagi M, Takashima Y, Sasazuki T,
et al: KRAS-mediated up-regulation of RRM2 expression is essential
for the proliferation of colorectal cancer cell lines. Anticancer
Res. 31:2535–2539. 2011.PubMed/NCBI
|
|
48
|
Li X, Chen W, Jia J, You Z, Hu C, Zhuang
Y, Lin Z, Liu Y, Yang C and Xu R: The long non-coding RNA-RoR
promotes the tumorigenesis of human colorectal cancer by targeting
miR-6833-3p through SMC4. Onco Targets Ther. 13:2573–2581. 2020.
View Article : Google Scholar : PubMed/NCBI
|
